Clinical

Dataset Information

0

FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer


ABSTRACT: The goal of the Phase I part of this clinical research study is to find the highest tolerable dose of a combination of dasatinib, cetuximab, and FOLFOX (5-fluorouracil [5-FU], leucovorin [LV], and Eloxatin [oxaliplatin]) that can be given to patients with metastatic colorectal cancer. The safety of these drugs in combination will also be studied. The goal of the Phase II part of this clinical research study is to learn if dasatinib given in combination with FOLFOX with or without cetuximab can help to control metastatic colorectal cancer.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2042092 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2011-03-25 | GSE21228 | GEO
2023-10-30 | PXD046566 |
2019-06-20 | GSE84269 | GEO
2019-06-20 | GSE84267 | GEO
2012-07-13 | E-GEOD-23428 | biostudies-arrayexpress
2023-07-20 | GSE232525 | GEO
| 2093710 | ecrin-mdr-crc
2012-07-14 | GSE23428 | GEO
| 2094460 | ecrin-mdr-crc
| 2073758 | ecrin-mdr-crc